Vivian W Sung1,2, Diane Borello-France3, Gena Dunivan4, Marie Gantz5, Emily S Lukacz6, Pamela Moalli7, Diane K Newman8, Holly E Richter9, Beri Ridgeway10, Ariana L Smith8, Alison C Weidner11, Susan Meikle12. 1. The Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Alpert Medical School of Brown University, Providence, RI, USA. vsung@wihri.org. 2. Women and Infants Hospital of Rhode Island Division of Urogynecology and Reconstructive Pelvic Surgery, Warren Alpert Medical School of Brown University, 101 Plain Street 5th floor, Providence, RI, 02903, USA. vsung@wihri.org. 3. Department of Physical Therapy, Rangos School of Health Sciences, Duquesne University, Pittsburgh, PA, USA. 4. The Division of Urogynecology, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM, USA. 5. Social, Statistical, & Environmental Sciences, RTI International, Research Triangle Park, NC, USA. 6. The Division of Female Pelvic Medicine & Reconstructive Surgery, Department of Reproductive Medicine, UC San Diego Health System, San Diego, CA, USA. 7. Women's Center for Bladder and Pelvic Health, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Urogynecology and Reconstructive Pelvic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 8. The Division of Urology, Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA. 9. Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama, USA. 10. Center for Urogynecology and Reconstructive Pelvic Surgery, Obstetrics, Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA. 11. Division of Urogynecology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA. 12. Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Abstract
INTRODUCTION AND HYPOTHESIS: Mixed urinary incontinence (MUI) can be a challenging condition to manage. We describe the protocol design and rationale for the Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence (ESTEEM) trial, designed to compare a combined conservative and surgical treatment approach versus surgery alone for improving patient-centered MUI outcomes at 12 months. METHODS: ESTEEM is a multisite, prospective, randomized trial of female participants with MUI randomized to astandardized perioperative behavioral/pelvic floor exercise intervention plus midurethral sling versus midurethral sling alone. We describe our methods and four challenges encountered during the design phase: defining the study population, selecting relevant patient-centered outcomes, determining sample size estimates using a patient-reported outcome measure, and designing an analysis plan that accommodates MUI failure rates. A central theme in the design was patient centeredness, which guided many key decisions. Our primary outcome is patient-reported MUI symptoms measured using the Urogenital Distress Inventory (UDI) score at 12 months. Secondary outcomes include quality of life, sexual function, cost-effectiveness, time to failure, and need for additional treatment. RESULTS: The final study design was implemented in November 2013 across eight clinical sites in the Pelvic Floor Disorders Network. As of 27 February 2016, 433 total/472 targeted participants had been randomized. CONCLUSIONS: We describe the ESTEEM protocol and our methods for reaching consensus for methodological challenges in designing a trial for MUI by maintaining the patient perspective at the core of key decisions. This trial will provide information that can directly impact patient care and clinical decision making.
RCT Entities:
INTRODUCTION AND HYPOTHESIS: Mixed urinary incontinence (MUI) can be a challenging condition to manage. We describe the protocol design and rationale for the Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence (ESTEEM) trial, designed to compare a combined conservative and surgical treatment approach versus surgery alone for improving patient-centered MUI outcomes at 12 months. METHODS: ESTEEM is a multisite, prospective, randomized trial of female participants with MUI randomized to a standardized perioperative behavioral/pelvic floor exercise intervention plus midurethral sling versus midurethral sling alone. We describe our methods and four challenges encountered during the design phase: defining the study population, selecting relevant patient-centered outcomes, determining sample size estimates using a patient-reported outcome measure, and designing an analysis plan that accommodates MUI failure rates. A central theme in the design was patient centeredness, which guided many key decisions. Our primary outcome is patient-reported MUI symptoms measured using the Urogenital Distress Inventory (UDI) score at 12 months. Secondary outcomes include quality of life, sexual function, cost-effectiveness, time to failure, and need for additional treatment. RESULTS: The final study design was implemented in November 2013 across eight clinical sites in the Pelvic Floor Disorders Network. As of 27 February 2016, 433 total/472 targeted participants had been randomized. CONCLUSIONS: We describe the ESTEEM protocol and our methods for reaching consensus for methodological challenges in designing a trial for MUI by maintaining the patient perspective at the core of key decisions. This trial will provide information that can directly impact patient care and clinical decision making.
Authors: Jennifer M Wu; Amie Kawasaki; Andrew F Hundley; Alexis A Dieter; Evan R Myers; Vivian W Sung Journal: Am J Obstet Gynecol Date: 2011-04-02 Impact factor: 8.661
Authors: Charles W Nager; Stephen R Kraus; Kim Kenton; Larry Sirls; Toby C Chai; Clifford Wai; Gary Sutkin; Wendy Leng; Heather Litman; Liyuan Huang; Sharon Tennstedt; Holly E Richter Journal: Neurourol Urodyn Date: 2010-09 Impact factor: 2.696
Authors: Kathryn L Burgio; Stephen R Kraus; Shawn Menefee; Diane Borello-France; Marlene Corton; Harry W Johnson; Veronica Mallett; Peggy Norton; Mary P FitzGerald; Kimberly J Dandreo; Holly E Richter; Thomas Rozanski; Michael Albo; Halina M Zyczynski; Gary E Lemack; Toby C Chai; Salil Khandwala; Jan Baker; Linda Brubaker; Anne M Stoddard; Patricia S Goode; Betsy Nielsen-Omeis; Charles W Nager; Kimberly Kenton; Sharon L Tennstedt; John W Kusek; T Debuene Chang; Leroy M Nyberg; William Steers Journal: Ann Intern Med Date: 2008-08-05 Impact factor: 25.391
Authors: Linda Brubaker; Anne Stoddard; Holly Richter; Philippe Zimmern; Pamela Moalli; Stephen R Kraus; Peggy Norton; Emily Lukacz; Larry Sirls; Harry Johnson Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696
Authors: Leslee L Subak; Linda Brubaker; Toby C Chai; Jennifer M Creasman; Ananias C Diokno; Patricia S Goode; Stephen R Kraus; John W Kusek; Wendy W Leng; Emily S Lukacz; Peggy Norton; Sharon Tennstedt Journal: Obstet Gynecol Date: 2008-04 Impact factor: 7.661
Authors: Yuko M Komesu; Holly E Richter; Darrell L Dinwiddie; Nazema Y Siddiqui; Vivian W Sung; Emily S Lukacz; Beri Ridgeway; Lily A Arya; Halina M Zyczynski; Rebecca G Rogers; Marie Gantz Journal: Int Urogynecol J Date: 2016-10-13 Impact factor: 2.894
Authors: Vivian W Sung; Diane Borello-France; Diane K Newman; Holly E Richter; Emily S Lukacz; Pamela Moalli; Alison C Weidner; Ariana L Smith; Gena Dunivan; Beri Ridgeway; John N Nguyen; Donna Mazloomdoost; Benjamin Carper; Marie G Gantz Journal: JAMA Date: 2019-09-17 Impact factor: 56.272
Authors: Nazema Y Siddiqui; Li Ma; Linda Brubaker; Jialiang Mao; Carter Hoffman; Erin M Dahl; Zhuoqun Wang; Lisa Karstens Journal: Front Cell Infect Microbiol Date: 2022-07-08 Impact factor: 6.073
Authors: Heidi S Harvie; Vivian W Sung; Simon J Neuwahl; Amanda A Honeycutt; Isuzu Meyer; Christopher J Chermansky; Shawn Menefee; Whitney K Hendrickson; Gena C Dunivan; Donna Mazloomdoost; Sarah J Bass; Marie G Gantz Journal: Am J Obstet Gynecol Date: 2021-07-06 Impact factor: 8.661
Authors: Holly E Richter; Megan U Carnes; Yuko M Komesu; Emily S Lukacz; Lily Arya; Megan Bradley; Rebecca G Rogers; Vivian W Sung; Nazema Y Siddiqui; Benjamin Carper; Donna Mazloomdoost; Darryl Dinwiddie; Marie G Gantz Journal: Am J Obstet Gynecol Date: 2021-07-21 Impact factor: 10.693
Authors: Yuko M Komesu; Holly E Richter; Benjamin Carper; Darrell L Dinwiddie; Emily S Lukacz; Nazema Y Siddiqui; Vivian W Sung; Halina M Zyczynski; Beri Ridgeway; Rebecca G Rogers; Lily A Arya; Donna Mazloomdoost; Marie G Gantz Journal: Int Urogynecol J Date: 2018-06-16 Impact factor: 1.932
Authors: Vivian W Sung; Holly E Richter; Pamela Moalli; Alison C Weidner; John N Nguyen; Ariana L Smith; Gena Dunivan; Beri Ridgeway; Diane Borello-France; Diane K Newman; Donna Mazloomdoost; Benjamin Carper; Marie G Gantz Journal: Obstet Gynecol Date: 2020-09 Impact factor: 7.623